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Background/aims: Isolated retinopathy signs are common in
non-diabetic individuals and have been shown to be
associated with impaired glucose metabolism. In a cohort
of people without diabetes, the association of these retino-
pathy signs and subsequent development of diabetes were
examined.
Methods: A population based cohort study of 7992 people
aged 49–73 years without diabetes was conducted. Retinal
photographs of these participants were evaluated for the
presence of retinopathy signs according to a standardised
protocol. Incident cases of diabetes were identified prospec-
tively.
Results: After a follow up of 3 years, 291 (3.6%) people
developed incident diabetes. In the total cohort, retinopathy
was not significantly associated with incident diabetes (4.7%
v 3.6%, multivariable adjusted odds ratio (OR) 1.1, 95%
confidence intervals (CI), 0.7 to 1.9). However, among
participants with a positive family history of diabetes,
retinopathy was associated with incident diabetes (10.4% v
4.8%, multivariable adjusted OR 2.3, 95% CI, 1.0 to 5.3).
Among participants without a family history of diabetes,
retinopathy was not associated with incident diabetes
Conclusions: In individuals with a family history of diabetes,
retinopathy signs predict subsequent risk of clinical diabetes.
I
solated retinal microaneurysms and haemorrhages are
some of the earliest visible lesions of retinopathy in people
with diabetes.1 2 In those without diabetes, the clinical
significance of these retinopathy signs is less clear.3
Population based studies indicate that retinopathy signs are
common,4 5 associated with hypertension,6 and predict
cardiovascular events.7 8
Few studies, however, have investigated if retinopathy is
preclinical marker of diabetes. Previous cross sectional
studies in non-diabetic individuals have shown that retino-
pathy signs are associated with impaired glucose metabo-
lism,9–12 but there are no prospective data linking retinopathy
to subsequent risk of clinical diabetes. In the current study,
we examined the predictive value of retinopathy signs to the
incidence of diabetes.
MATERIALS AND METHODS
The Atherosclerosis Risk In Communities study is a popula-
tion based cohort study that included 15 792 people 45–
64 years of age selected from four US communities at
baseline (1987–9).13 Participants underwent follow up at
3 yearly intervals, and retinal photographs were taken at the
third examination (1993–5). Of the 12 887 participants who
returned for the third examination, we excluded 80
non-white, non-black participants, 2399 with prevalent
diabetes, 1392 with no retinal photographs or ungradeable
photographs, and 1024 who did not return for the fourth
examination (1996–8), leaving 7992 for this study.14
Institutional review boards at each study site and at the
Fundus Photograph Reading Center at the University of
Wisconsin, Madison, approved the study. Informed consent
was obtained from all participants and the study was
conducted in accordance with the Declaration of Helsinki.
The retinal photography procedure has been described.14 15
Briefly, a non-mydriatic retinal photograph of one randomly
selected eye was taken and graded for retinopathy according
to standardised protocol. Retinopathy was defined as
presence of microaneurysms, haemorrhages, cotton wool
spots, and/or hard exudates.15
Incident diabetes mellitus was defined as participants with
a fasting serum glucose of >7.0 mmol/l, non-fasting glucose
>11.1 mmol/l, diabetic medications use or physician diag-
nosis of diabetes at the fourth visit.14 An alternative definition
of incident diabetes included the additional criterion of a
2 hour post-load serum glucose of >11.1 mmol/l based on a
75 g oral glucose tolerance test at the fourth examination
(this was not performed at the third examination).14
Participants underwent interview, physical examination,
and laboratory investigations.13 A positive family history of
diabetes was defined by self report of diabetes in either
biological parent. The mean arterial blood pressure (O
diastolic + M systolic), averaged over the first three
examinations (that is, 6 year mean arterial blood pressure),
was included as a covariate in the analysis.7
We used logistic regression to estimate odds ratio of
incident diabetes according to retinopathy status, adjusting
initially for other factors. We evaluated associations initially
in the total cohort and then performed stratified analysis
with a number of potential effect modifiers: family history of
diabetes (absence, presence), hypertension (absence, pre-
sence), fasting glucose (,6.1, 6.1–6.9 mmol/l), and body
mass index (,28, >28 kg/m2). We also formally tested for
interactions by adding cross product terms in these models
(for example, retinopathy 6 family history).
RESULTS
Participants with retinopathy (n = 381, 4.8%) were more
likely to be men and be African-Americans, and to have
higher systolic and diastolic blood pressure and higher
fasting insulin levels than participants without retinopathy
(all comparisons p,0.05, data not shown). Participants with
and without retinopathy did not differ with respect to age,
family history of diabetes, fasting glucose, body mass index,
and cigarette smoking status (p.0.05, data not shown)
Over a median follow up of 3.5 years, 291 people developed
incident diabetes. In the total cohort, retinopathy was not
significantly associated with incident diabetes (table 1).
However, when stratified by family history of diabetes,
among participants with a positive family history, retino-
pathy was significantly associated with incident diabetes.
This association was not present among participants without
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a family history of diabetes. The interaction between
retinopathy and family history of diabetes was statistically
significant (p = 0.04).
There were 713 cases of incident diabetes using the
alternative definition. The pattern of associations was largely
similar (table 1).
Other diabetes risk factors (hypertension, fasting glucose,
body mass index) did not significantly modify the relation of
retinopathy and incident diabetes (data not shown).
DISCUSSION
Overall, retinopathy was not associated with the 3 year
incidence of diabetes. However, among those with a positive
family history of diabetes, retinopathy predicted subsequent
onset of clinical diabetes, independent of blood pressure,
fasting glucose, fasting insulin, and body mass index.
Individuals with a family history of diabetes have been
reported to have early abnormalities of glucose metabolism,16
microvascular dysfunction,17 18 and an increased risk of overt
diabetes.19 20 Previous studies have shown that retinopathy
signs are common in people with impaired glucose metabo-
lism.9–12 Thus, among individuals with a family history of
diabetes, retinopathy may be a marker of underlying
abnormalities in glucose metabolism or microvascular dis-
ease.
The lack of association between retinopathy and incident
diabetes among people without a family history of diabetes
may be because retinopathy signs in these people reflect
other pathogenic conditions (for example, hypertension).3 6 It
is also possible that the modification of the association of
retinopathy and incident diabetes by family history is a
chance finding.
Strengths of this study include a well characterised sample,
masked evaluation of retinopathy, and standardised identi-
fication of incident diabetes. Limitations include the follow-
ing. Firstly, retinopathy may be missed because of availability
of only one eye for assessment. Secondly, the single glucose
determination and relatively short follow up may have led to
misclassification of diabetes. However, the fact that our
results were similar with an alternative diabetes definition
probably minimises misclassification.
In conclusion, in people with a family history of diabetes,
retinopathy is predictive of subsequent risk of clinical
diabetes independent of other risk factors.
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Incident diabetes* Incident diabetes (alternative)*
Numbers
at risk %
Age, sex, race Multivariate
%
Age, sex, race Multivariate
OR (95% CI) OR (95% CI)` OR (95% CI) OR (95% CI)`
All people
Absent 7,611 3.6 1.0 1.0 8.9 1.0 1.0
Present 381 4.7 1.2 (0.7 to 2.0) 1.1 (0.7 to 1.9) 10.9 1.2 (0.9 to 1.7) 1.1 (0.8 to 1.6)
No family history of diabetes
Absent 5,961 3.2 1.0 1.0 8.3 1.0 1.0
Present 304 3.3 0.9 (0.4 to 1.7) 0.8 (0.4 to 1.6) 8.7 1.0 (0.6 to 1.5) 0.9 (0.5 to 1.3)
Family history of diabetes
Absent 1,650 4.8 1.0 1.0 11.0 1.0 1.0
Present 77 10.4 2.5 (1.1 to 5.3) 2.3 (1.0 to 5.3) 19.5 2.1 (1.2 to 3.8) 2.0 (1.1 to 3.8)
*Incident diabetes defined as fasting serum glucose of >7.0 mmol/l, casual glucose >11.1 mmol/l, diabetic medications use, or physician diagnosis of diabetes.
Alternative definition of incident diabetes includes these criteria or a 2 hour post-load serum glucose of >11.1 mmol/l.
Odds ratio (95% confidence interval) of incident diabetes, adjusted for age, sex, and race
`Odds ratio (95% confidence interval) of incident diabetes, adjusted for age, sex, race, fasting glucose, fasting insulin, 6 year mean arterial blood pressure, and
body mass index.
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